NCT03878849 2025-08-28Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian CancerAllarity TherapeuticsPhase 2 Recruiting40 enrolled
NCT04556539 2021-05-12Study of SC10914 in Patients With gBRCA1/2 Mutation Advanced Ovarian CancerJiangxi Qingfeng Pharmaceutical Co. Ltd.Phase 2 Unknown104 enrolled